Targeted Medical(TRGM)
USD --+0.00%
Reward35Moderate
Risk68Medium-High
📊75%Data
Thin -58% profit margin · Revenue down 9% YoY
TRGM
+0.0 · +0.00%
USD · PINK
Targeted Medical | Healthcare
Earnings Deterioration
Market Cap:3018
ℹ️
Reward Rating
35
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
68
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on TRGM to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Targeted Medical?

, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

TRGM · Verdict

Limited reward · elevated risk

TRGM stands out on volatility and valuation, but watch the balance sheet signal.

Based on 88% data coverage

TRGM · Verdict

What’s working & what to watch

Strengths 2

  • Volatility75/100

    Above average

  • Valuation67/100

    Above average

Watchouts 4

  • Balance sheet14/100

    Current ratio 0.06

  • Growth15/100

    Rev -10.3% CAGR · earnings -31.8%

  • Cash flow20/100

    -24% free-cash-flow margin

  • Profitability32/100

    -58% net margin · 0% ROE

Model-based scoring. For information only — not financial advice.

What is Targeted Medical?

, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.02K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (35)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap3.02K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0001
52 Week Low0.0001
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding30M
No. of Employees30
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta-0.306
CurrencyUSD